Galmed Pharmaceuticals Ltd. — All Filings
351 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
20-F
20-F/A
3
424A
424B3
424B4
424B5
6-K
6-K/A
8-A12B
CERTNAS
CORRESP
CT ORDER
D
DRS
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
FWP
POS AM
POS EX
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | 3 | 0001493152-26-010845 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010846 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010842 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010850 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010848 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010847 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010843 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010849 | Mar 18, 2026 | — |
| 3 | 3 | 0001493152-26-010844 | Mar 18, 2026 | — |
| 6-K | 6-K | 0001493152-26-008989 | Mar 5, 2026 | — |
| 6-K | 6-K | 0001493152-26-008858 | Mar 4, 2026 | — |
| 6-K | 6-K | 0001493152-26-005776 | Feb 9, 2026 | — |
| 6-K | 6-K | 0001493152-26-004508 | Jan 30, 2026 | — |
| 6-K | 6-K | 0001493152-25-026539 | Dec 8, 2025 | — |
| 6-K | 6-K | 0001493152-25-026112 | Dec 4, 2025 | — |
| 6-K | 6-K | 0001493152-25-025498 | Dec 1, 2025 | — |
| 6-K | 6-K | 0001493152-25-025070 | Nov 26, 2025 | Sep 30, 2025 |
| 6-K | 6-K | 0001493152-25-024004 | Nov 18, 2025 | — |
| 6-K | 6-K | 0001493152-25-023777 | Nov 17, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000198 | Nov 7, 2025 | — |
| 6-K | 6-K | 0001493152-25-020057 | Oct 29, 2025 | — |
| 6-K | 6-K | 0001493152-25-019879 | Oct 28, 2025 | — |
| S-8 | S-8 | 0001493152-25-014250 | Sep 19, 2025 | — |
| 6-K | 6-K | 0001493152-25-014239 | Sep 19, 2025 | — |
| EFFECT | — | 9999999995-25-002804 | Sep 2, 2025 | — |
| EFFECT | — | 9999999995-25-002797 | Sep 2, 2025 | — |
| POS AM | POS AM | 0001493152-25-012441 | Aug 28, 2025 | — |
| POS AM | POS AM | 0001493152-25-012440 | Aug 28, 2025 | — |
| 6-K | 6-K | 0001493152-25-012420 | Aug 28, 2025 | Jun 30, 2025 |
| 6-K | 6-K | 0001493152-25-012291 | Aug 25, 2025 | — |
| EFFECT | — | 9999999995-25-002710 | Aug 21, 2025 | — |
| 424B3 | 424B3 | 0001641172-25-025094 | Aug 21, 2025 | — |
| CORRESP | — | 0001641172-25-025014 | Aug 21, 2025 | — |
| UPLOAD | — | 0000000000-25-008880 | Aug 20, 2025 | — |
| F-1 | F-1 | 0001641172-25-024659 | Aug 18, 2025 | — |
| 6-K | 6-K | 0001641172-25-024365 | Aug 15, 2025 | — |
| 6-K | 6-K | 0001641172-25-024005 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000153 | Aug 14, 2025 | — |
| 6-K | 6-K | 0001641172-25-020838 | Jul 24, 2025 | — |
| 6-K | 6-K | 0001641172-25-012398 | May 27, 2025 | — |
| 6-K | 6-K | 0001641172-25-011985 | May 22, 2025 | — |
| 6-K | 6-K | 0001641172-25-009844 | May 13, 2025 | — |
| 6-K | 6-K | 0001641172-25-008753 | May 6, 2025 | — |
| 6-K | 6-K | 0001641172-25-006351 | Apr 28, 2025 | — |
| 6-K | — | 0001641172-25-005169 | Apr 17, 2025 | — |
| 6-K | — | 0001641172-25-004714 | Apr 15, 2025 | — |
| 6-K | — | 0001641172-25-003523 | Apr 10, 2025 | — |
| EFFECT | — | 9999999995-25-001032 | Apr 8, 2025 | — |
| POS AM | — | 0001641172-25-002375 | Apr 2, 2025 | — |
| 20-F | — | 0001641172-25-002362 | Apr 2, 2025 | Dec 31, 2024 |